Workflow
Kadant Reports Third Quarter 2025 Results
Globenewswire· 2025-10-28 21:03
Core Insights - Kadant Inc. reported its third-quarter financial results for the period ending September 27, 2025, highlighting solid performance despite ongoing challenges in demand for capital equipment and global trade uncertainties [1][3]. Financial Performance - Revenue for the third quarter was $271.6 million, unchanged from the previous year, with organic revenue decreasing by four percent, offset by a two percent increase from acquisitions and a two percent favorable foreign currency translation effect [4]. - Gross margin improved to 45.2% from 44.7% in the prior year [4]. - Net income decreased by 12% to $27.7 million compared to $31.6 million in 2024, with GAAP EPS also down 12% to $2.35 [5]. - Adjusted EPS fell by nine percent to $2.59, excluding acquisition-related costs [5]. - Adjusted EBITDA decreased by eight percent to $58.0 million, representing 21.4% of revenue, down from 23.3% in 2024 [6][27]. - Operating cash flow decreased by 10% to $47.3 million, while free cash flow decreased by nine percent to $44.1 million [6][26]. Bookings and Outlook - Bookings decreased by one percent to $238.4 million, with organic bookings down four percent [7]. - The company anticipates healthy demand for aftermarket parts and improving order activity for capital equipment in the fourth quarter, revising revenue guidance for 2025 to $1.036 to $1.046 billion [8]. - Adjusted EPS guidance remains at $9.05 to $9.25, while GAAP EPS is expected to be between $8.52 and $8.72 [8]. Segment Performance - The Flow Control segment reported revenue of $94.8 million, down from $97.5 million, while Industrial Processing revenue decreased to $106.4 million from $110.7 million [24]. - Material Handling segment revenue increased to $70.3 million from $63.4 million [24]. - The percentage of revenue from parts and consumables increased to 69% from 65% [24]. Company Overview - Kadant Inc. is a global supplier of technologies and engineered systems that enhance efficiency and productivity in process industries, with approximately 3,900 employees across 22 countries [29].
MariMed Announces Strategic Exit From Missouri Market
Globenewswire· 2025-10-28 21:00
NORWOOD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced that it has completed a strategic review of its Missouri business operations and decided to exit the market, effectively immediately. Since 2024, the Company has managed the Missouri operations of another licensed cannabis operator and distributed certain of its brands there under a Managed Services and Licensing Agreement, whi ...
Itron Supports Virtual Power Plants in Australia
Globenewswire· 2025-10-28 21:00
Itron Solution Remotely Manages 100 MWh of Distributed Energy Resource CapacityLIBERTY LAKE, Wash., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, is supporting Project Jupiter to accelerate the integration of distributed energy resources (DER) using components of Itron’s Low Voltage Distributed Energy Resource Management System (LV DERMS). A collaboration between Western Power, Synergy, the Australian Energy Ma ...
First Commonwealth Announces Third Quarter 2025 Earnings; Declares Quarterly Dividend
Globenewswire· 2025-10-28 21:00
Financial Summary - First Commonwealth Financial Corporation reported a GAAP net income of $41.3 million for Q3 2025, an increase of $7.9 million from Q2 2025 and $9.2 million from Q3 2024 [4][8] - Diluted earnings per share (EPS) for Q3 2025 was $0.39, up from $0.32 in Q2 2025 and $0.31 in Q3 2024 [4][8] - Core net income was $41.2 million, representing a $1.7 million increase from the previous quarter and a $9.2 million increase from the same quarter last year [4][8] - Core diluted EPS was also $0.39, compared to $0.38 in Q2 2025 and $0.31 in Q3 2024 [4][8] Profitability - The return on average assets (ROA) increased to 1.34% in Q3 2025, up from 1.11% in Q2 2025 [4][10] - The return on average equity (ROE) improved to 10.71% from 8.97% in the previous quarter [4][10] - The core efficiency ratio improved to 52.30%, down from 54.06% in Q2 2025 [4][21] Asset Quality - The provision for credit losses was $11.3 million, an increase of $2.4 million from the previous quarter [10][14] - Nonperforming loans decreased to $88.7 million, down $10.8 million from the previous quarter [15][16] - Net charge-offs totaled $12.2 million, an increase from $2.8 million in the previous quarter [17][18] Net Interest Income and Margin - Net interest income (FTE) for Q3 2025 was $111.5 million, an increase of $4.9 million from Q2 2025 [11][12] - The net interest margin expanded to 3.92%, up 9 basis points from the previous quarter [12][10] - Total average deposits grew by $102.7 million, or 4.0% annualized, compared to the previous quarter [12][10] Dividends and Capital - The company declared a quarterly cash dividend of $0.135 per share, a 3.9% increase from Q3 2024 [23] - Total shareholder's equity increased by $24.1 million from the previous quarter [10][24] - The Bank-level Total Capital ratio was 13.4%, exceeding the regulatory "well capitalized" requirement of 10.0% [10][24]
DIRTT to Announce Third Quarter 2025 Financial Results on November 5, 2025
Globenewswire· 2025-10-28 21:00
CALGARY, Alberta, Oct. 28, 2025 (GLOBE NEWSWIRE) -- DIRTT Environmental Solutions Ltd. (“DIRTT”, the “Company”, “we”, “our”, “us” or “ours”) (TSX: DRT; OTCQX: DRTTF), a leader in industrialized construction, announced today that it will release its third quarter 2025 financial results on Wednesday, November 5, 2025, after markets close. Webcast Information:In conjunction with the release, the executive team has scheduled a conference call to discuss the company’s results. The call will be broadcast live via ...
BellRing Brands Announces Timing of Fiscal Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call
Globenewswire· 2025-10-28 21:00
Core Insights - BellRing Brands, Inc. will release its financial results for Q4 and fiscal year 2025 on November 18, 2025, at 7:00 a.m. ET, followed by a conference call at 8:30 a.m. ET [1] - The conference call will feature Darcy H. Davenport, President and CEO, and Paul A. Rode, CFO, discussing the results and outlook [1] Company Overview - BellRing Brands, Inc. is a fast-growing consumer brands business focused on the convenient nutrition category, with brands including Premier Protein and Dymatize [3] - Premier Protein is recognized as the 1 ready-to-drink protein and convenient nutrition brand, while Dymatize is known for the 1 hydrolyzed protein powder [3] - The company distributes its products in over 90 countries across various channels, including club, mass, food, eCommerce, specialty, drug, and convenience [3]
Toll Brothers Announces Model Grand Opening at Chevy Chase Crossing in Chevy Chase, Maryland
Globenewswire· 2025-10-28 20:56
Model Grand Opening Event this Saturday, Nov. 1 will showcase new luxury townhomes offering modern designs and unmatched convenience just minutes from Washington, D.C.CHEVY CHASE, Md., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the grand opening of its new model homes at Chevy Chase Crossing, a luxury townhome community in Chevy Chase, Maryland. The public is invited to a Grand Opening Event at the community to tour the new ...
Insight Digital Partners II Announces Pricing of $150 Million Initial Public Offering
Globenewswire· 2025-10-28 20:55
Group 1 - The company, Insight Digital Partners II, has announced the pricing of its initial public offering (IPO) of 15,000,000 units at a price of $10.00 per unit, expected to trade on Nasdaq under the ticker symbol "DYORU" starting October 29, 2025 [1] - Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share [1] - The offering is expected to close on October 30, 2025, and the company has granted underwriters a 45-day option to purchase an additional 2,250,000 units to cover over-allotments [3] Group 2 - Insight Digital Partners II is a blank check company formed to effect a merger or similar business combination, targeting high-growth sectors within the digital economy, including infrastructure for stablecoins, digital payments, and high-performance computing [2] - The company aims to pursue opportunities in sectors that are expected to have a significant impact on the digital economy, focusing on innovative energy solutions that support these advancements [2] Group 3 - Cohen & Company Capital Markets is acting as the sole book-running manager for the offering, and the offering is being made only by means of a prospectus [3][5] - A registration statement relating to these securities was filed with the SEC and became effective, allowing the company to proceed with the IPO [4]
Sound Financial Bancorp, Inc. Q3 2025 Results
Globenewswire· 2025-10-28 20:54
Core Insights - Sound Financial Bancorp reported a net income of $1.7 million for Q3 2025, a decrease from $2.1 million in Q2 2025 and an increase from $1.2 million in Q3 2024, with diluted earnings per share of $0.66 [1] - The Board of Directors declared a cash dividend of $0.19 per share, payable on November 21, 2025 [1] Financial Performance - Total assets increased by $1.9 million or 0.2% to $1.06 billion at September 30, 2025, but decreased by $40.8 million or 3.7% from $1.10 billion at September 30, 2024 [5] - Loans held-for-portfolio increased by $5.4 million or 0.6% to $909.7 million at September 30, 2025, compared to $901.7 million at September 30, 2024 [5][35] - Total deposits decreased by $516 thousand or 0.1% to $898.9 million at September 30, 2025, and decreased by $31.3 million or 3.4% from $930.2 million at September 30, 2024 [6][40] Interest Income and Expenses - Net interest income decreased by $315 thousand or 3.4% to $8.9 million for Q3 2025, but increased by $1.1 million or 13.6% from $7.9 million in Q3 2024 [7][12] - The net interest margin was 3.48% for Q3 2025, down from 3.67% in Q2 2025 and up from 2.98% in Q3 2024 [8] - Interest expense increased by $52 thousand or 0.9% to $5.7 million for Q3 2025, compared to Q2 2025 [16] Credit Quality - Total nonperforming loans decreased by $649 thousand or 19.3% to $2.7 million at September 30, 2025, compared to the previous quarter [7] - A provision for credit losses of $55 thousand was recorded for Q3 2025, down from $170 thousand in Q2 2025 [9][17] - The allowance for credit losses on loans to total loans outstanding was 0.94% at September 30, 2025, compared to 0.95% at September 30, 2024 [9][37] Noninterest Income and Expenses - Total noninterest income decreased by $239 thousand or 21.3% to $881 thousand for Q3 2025, compared to Q2 2025 [10][24] - Noninterest expense remained stable at $7.7 million for Q3 2025, with slight fluctuations in specific categories [28][30] Capital Management - Stockholders' equity totaled $107.5 million at September 30, 2025, an increase of $1.4 million or 1.4% from the previous quarter [42] - The company maintained capital levels in excess of regulatory requirements and was categorized as "well-capitalized" at September 30, 2025 [11]
Ultragenyx to Host Conference Call for Third Quarter 2025 Financial Results and Corporate Update
Globenewswire· 2025-10-28 20:30
Core Insights - Ultragenyx Pharmaceutical Inc. will host a conference call on November 4, 2025, to discuss its financial results and corporate updates for Q3 2025 [1] - The call will be accessible via the company's website, with a replay available for three months [2] Company Overview - Ultragenyx is a biopharmaceutical company focused on developing and commercializing novel products for serious rare and ultra-rare genetic diseases [3] - The company has a diverse portfolio of approved therapies and product candidates targeting diseases with high unmet medical needs [3] - Ultragenyx's management team has extensive experience in the development and commercialization of therapeutics for rare diseases [4] - The company's strategy emphasizes time- and cost-efficient drug development to deliver safe and effective therapies urgently [4]